Antares Pharma (ATRS) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Antares Pharma Reports First Quarter 2016 Operating and Financial Results
May 9, 2016 7:01 AM EDTEWING, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the first quarter ended March 31, 2016. The Company reported revenue of $12.3 million compared to $8.3 million for the comparable period in 2015, and net loss per share of $0.05 for both periods.Â
The Company reported another solid quarter of top line growth, with the primary driver of that growth coming once again from an increase in product revenue, said Robert F. Apple, President and Chief Executive Officer of the Company. Antares also reported significant progress... More
